NEW YORK, NY – October 26, 2023 – Investors in regeneron Pharmaceuticals, Inc. (REGN) have a limited time to seek legal counsel in a securities class action lawsuit, announced today by the Rosen Law Firm, P.A. The firm is investigating potential violations of federal securities laws on behalf of Regeneron investors.
The Rosen Law Firm alleges that Regeneron may have issued false and misleading statements to investors.This action impacts individuals who purchased Regeneron Pharmaceuticals, Inc. (REGN) securities between May 3, 2023, and October 6, 2023. A lead plaintiff motion deadline is set for November 21, 2023, for those wishing to take action.
The Rosen Law Firm encourages investors to contact them to discuss their potential rights and options. Investors seeking information can reach Laurence Rosen, Esq., or Phillip Kim, Esq., at the Rosen Law Firm, P.A., located at 275 Madison Avenue, 40th Floor, New York, NY 10016, via telephone at (212) 686-1060 or toll-free at (866) 767-3653. Further details are available via email at case@rosenlegal.com or on the firm’s website at www.rosenlegal.com.
Founded in 2000,the Rosen Law Firm represents investors globally,specializing in securities class action litigation and corporate governance disputes. The firm has recovered billions of dollars for investors and has a track record of representing clients in high-profile cases.
Contact:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New york, NY 10016
Tel: (212) 686-1060
toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com
